New insider activity at Alignment Healthcare ( (ALHC) ) has taken place on September 19, 2025.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Director General Atlantic (ALN HLTH), L.P. and Director General Atlantic LLC have each sold 6,246,096 shares of Alignment Healthcare stock, with each transaction valued at $99,999,996.
Recent Updates on ALHC stock
Alignment Healthcare’s stock has experienced a decline of 6.6% to $15.37 following a significant block trade of 13.46 million shares priced between $16.08 and $16.45, managed by Morgan Stanley. This price movement comes amid the company’s optimistic projections of reaching $5 billion to $6 billion in revenue over the next three years and achieving cash flow positivity a year ahead of schedule. Additionally, Alignment Healthcare’s strategy discussions and expected high Medicare Advantage Star ratings for 2026 were highlighted in recent investor meetings, potentially boosting its competitive positioning. However, despite strategic improvements and positive technical indicators, concerns about profitability and valuation persist, impacting the overall stock score.
Spark’s Take on ALHC Stock
According to Spark, TipRanks’ AI Analyst, ALHC is a Neutral.
Alignment Healthcare’s overall stock score reflects strong earnings call performance and positive technical analysis, offset by challenges in financial performance and valuation. The company’s strategic positioning and corporate events add to its positive outlook, but profitability remains a key concern.
To see Spark’s full report on ALHC stock, click here.
More about Alignment Healthcare
YTD Price Performance: 42.56%
Average Trading Volume: 3,781,514
Technical Sentiment Signal: Strong Buy
Current Market Cap: $3.3B